Emergent Biosolutions Return On Equity vs. Shares Owned By Insiders
| EBS Stock | USD 10.12 0.01 0.1% |
Return On Equity | First Reported 2010-12-31 | Previous Quarter (1.17) | Current Value (1.11) | Quarterly Volatility 0.43076408 |
For Emergent Biosolutions profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Emergent Biosolutions to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Emergent Biosolutions utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Emergent Biosolutions's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Emergent Biosolutions over time as well as its relative position and ranking within its peers.
Emergent |
Emergent Biosolutions' Revenue Breakdown by Earning Segment
Check out Investing Opportunities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Emergent Biosolutions. If investors know Emergent will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Emergent Biosolutions listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.022 | Earnings Share (11.22) | Revenue Per Share 21.448 | Quarterly Revenue Growth 0.086 | Return On Assets (0.04) |
The market value of Emergent Biosolutions is measured differently than its book value, which is the value of Emergent that is recorded on the company's balance sheet. Investors also form their own opinion of Emergent Biosolutions' value that differs from its market value or its book value, called intrinsic value, which is Emergent Biosolutions' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Emergent Biosolutions' market value can be influenced by many factors that don't directly affect Emergent Biosolutions' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Emergent Biosolutions' value and its price as these two are different measures arrived at by different means. Investors typically determine if Emergent Biosolutions is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Emergent Biosolutions' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Emergent Biosolutions Shares Owned By Insiders vs. Return On Equity Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Emergent Biosolutions's current stock value. Our valuation model uses many indicators to compare Emergent Biosolutions value to that of its competitors to determine the firm's financial worth. Emergent Biosolutions is rated # 3 in return on equity category among its peers. It also is rated # 3 in shares owned by insiders category among its peers . At this time, Emergent Biosolutions' Return On Equity is comparatively stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Emergent Biosolutions by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Emergent Shares Owned By Insiders vs. Return On Equity
Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Emergent Biosolutions |
| = | -0.35 |
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.
Emergent Biosolutions |
| = | 2.15 % |
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.
Emergent Shares Owned By Insiders Comparison
Emergent Biosolutions is currently under evaluation in shares owned by insiders category among its peers.
Emergent Biosolutions Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Emergent Biosolutions, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Emergent Biosolutions will eventually generate negative long term returns. The profitability progress is the general direction of Emergent Biosolutions' change in net profit over the period of time. It can combine multiple indicators of Emergent Biosolutions, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | -5.7 M | -6 M | |
| Operating Income | -726.4 M | -690.1 M | |
| Income Before Tax | -731.2 M | -694.6 M | |
| Total Other Income Expense Net | -4.8 M | -5 M | |
| Net Loss | -760.5 M | -722.5 M | |
| Income Tax Expense | 29.3 M | 24.3 M | |
| Net Loss | -257.4 M | -244.5 M | |
| Net Loss | -790.2 M | -750.7 M | |
| Non Operating Income Net Other | -10.5 M | -10 M | |
| Interest Income | 42.9 M | 22 M | |
| Net Interest Income | -79 M | -75 M | |
| Change To Netincome | 48.1 M | 44.4 M | |
| Net Loss | (14.85) | (14.11) | |
| Income Quality | 0.27 | 0.26 | |
| Net Income Per E B T | 1.04 | 0.59 |
Emergent Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Emergent Biosolutions. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Emergent Biosolutions position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Emergent Biosolutions' important profitability drivers and their relationship over time.
Use Emergent Biosolutions in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Emergent Biosolutions position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Emergent Biosolutions will appreciate offsetting losses from the drop in the long position's value.Emergent Biosolutions Pair Trading
Emergent Biosolutions Pair Trading Analysis
The ability to find closely correlated positions to Emergent Biosolutions could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Emergent Biosolutions when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Emergent Biosolutions - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Emergent Biosolutions to buy it.
The correlation of Emergent Biosolutions is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Emergent Biosolutions moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Emergent Biosolutions moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Emergent Biosolutions can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Emergent Biosolutions position
In addition to having Emergent Biosolutions in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run JPY Crypto Assets Thematic Idea Now
JPY Crypto Assets
An experimental p2p digital currency that is accepted by many vendors in Japanese Yen. The JPY Crypto Assets theme has 0 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize JPY Crypto Assets Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Emergent Stock Analysis
When running Emergent Biosolutions' price analysis, check to measure Emergent Biosolutions' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Emergent Biosolutions is operating at the current time. Most of Emergent Biosolutions' value examination focuses on studying past and present price action to predict the probability of Emergent Biosolutions' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Emergent Biosolutions' price. Additionally, you may evaluate how the addition of Emergent Biosolutions to your portfolios can decrease your overall portfolio volatility.